- MCL1 INHIBITORS AND USES THEREOF
-
The present disclosure provides compounds, such as compounds of Formula I, and compositions that are MCL1 inhibitors.
- -
-
Page/Page column 304; 305
(2021/04/10)
-
- HETEROCYCLIC AMIDES AS KINASE INHIBITORS
-
Disclosed are compounds having the formula: wherein R1 and R2 are as defined herein, and methods of making and using the same.
- -
-
-
- PYRIDINEAMINE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS
-
The present disclosure describes pyridineamine compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer, immune disorders and other diseases. Formula (I).
- -
-
Page/Page column 121
(2016/12/22)
-
- NEW THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description.
- -
-
Page/Page column 163
(2015/07/15)
-
- 2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS
-
The present invention relates to novel compounds of formula (I), wherein R1 is C1-4alkyl; R2 is C1-4alkyl, C3-7cycloalkyl, -CH2CF3, -CH2OCH3 or heterocyclyl; R3 is C1-4alkyl, -CH2F, -CH2OH or -CH2O(O)CH3; R4 when present is as defined in claim 1; R5 when present is H, halo, hydroxy or C1-6alkoxy; A is -NH-, -O-, -S-, -SO-, -SO2-, -N(C1-4alkyl)- or -NC(O)(CH3)-; V is phenyl, heteroaromatic or pyridone any of which may be optionally substituted by 1, 2 or 3 substituents; W is CH or N; X is C or N; Y is C or N; and Z is CH or N; subject to the proviso that no more than 2 of W, X, Y and Z are N, pharmaceutical compositions containing such compounds and to their use as bromodomain inhibitors.
- -
-
Page/Page column 170
(2014/09/29)
-
